Kuga-gun, Japan

Naoto Ohnishi


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Kuga-gun, JP (1997 - 1999)
  • Yamaguchi, JP (2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naoto Ohnishi: Innovator in Taxane-Type Diterpene Production

Introduction

Naoto Ohnishi is a prominent inventor based in Kuga-gun, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of taxane-type diterpenes, which are crucial for developing therapeutic agents for cancer treatment. With a total of 3 patents, Ohnishi's work has paved the way for advancements in industrial production methods.

Latest Patents

Ohnishi's latest patents focus on innovative methods for producing taxane-type diterpenes. One notable invention involves culturing plant tissues or cells in the presence of specific compounds, such as jasmonic acids and heavy metal ions, to enhance production rates. Another method emphasizes controlling oxygen concentrations in the culture environment to optimize growth conditions. These inventions aim to facilitate the industrial production of taxane-type diterpenes, including taxol, which is recognized for its therapeutic benefits in cancer treatment.

Career Highlights

Throughout his career, Naoto Ohnishi has worked with notable companies, including Mitsui Chemicals, Inc. and Mitsui Petrochemical Industries, Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Ohnishi has collaborated with esteemed colleagues, including Yukihito Yukimune and Yasuhiro Hara. These partnerships have further enriched his research and development efforts in the production of taxane-type diterpenes.

Conclusion

Naoto Ohnishi's contributions to the field of biotechnology, particularly in the production of taxane-type diterpenes, highlight his innovative spirit and dedication to advancing cancer treatment. His patents and collaborations reflect a commitment to improving industrial production methods for vital therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…